PMID: 7543680Aug 1, 1995Paper

Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas

Proceedings of the National Academy of Sciences of the United States of America
K YoshiuraS Hirohashi

Abstract

E-Cadherin, a cell adhesion molecule, which plays a key role in maintaining the epithelial phenotype, is regarded as an invasion-suppressor gene in light of accumulating evidence from in vitro experiments and clinical observations. In an attempt to clarify the mechanism responsible for inactivation of this gene in carcinomas, we investigated the methylation state around the promoter region by digestion of DNA with the methylation-sensitive restriction enzyme Hpa II, as CpG methylation of the promoter has been postulated to be a mechanism of transcriptional inactivation of some genes. We found that E-cadherin expression-negative carcinoma cell lines were accompanied by the hypermethylation state, whereas E-cadherin-positive cell lines were not. Furthermore, treatment of E-cadherin-negative carcinoma cells with the demethylating agent 5-azacytidine resulted in reexpression of the gene and reversion of scattered spindle-shaped cells to cells with epithelial morphology. These results suggest that hypermethylation around the promoter may be a mechanism of E-cadherin inactivation in human carcinomas and that treatment of E-cadherin-inactivated cells with a demethylating agent may cause gene expression reversion leading to epithelial ...Continue Reading

References

Mar 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·M MakosS B Baylin
Jul 10, 1992·Cell·A Bird
Dec 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·J BehrensW Birchmeier
Apr 1, 1991·The Journal of Cell Biology·U H FrixenW Birchmeier
Aug 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·P A JonesS J Tapscott
May 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·I KeshetH Cedar
Jun 25, 1981·Nucleic Acids Research·P A Jones, S M Taylor
Jul 19, 1994·Proceedings of the National Academy of Sciences of the United States of America·B D'souza, J Taylor-Papadimitriou
Oct 11, 1994·Proceedings of the National Academy of Sciences of the United States of America·J G HermanW M Linehan
Oct 25, 1994·Proceedings of the National Academy of Sciences of the United States of America·M ZionY Ben-Neriah
Oct 1, 1994·Japanese Journal of Cancer Research : Gann·Y KanaiS Hirohashi
Nov 22, 1994·Proceedings of the National Academy of Sciences of the United States of America·W H LeeW G Nelson
May 1, 1994·Nature Genetics·J I RisingerJ Boyd
Mar 1, 1994·Proceedings of the National Academy of Sciences of the United States of America·T OdaS Hirohashi
Nov 25, 1993·Nature·E LiR Jaenisch
Dec 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·B C SorkinG M Edelman

❮ Previous
Next ❯

Citations

Mar 29, 2000·Journal of Cellular Physiology·R L Momparler, V Bovenzi
Nov 24, 1999·Genes, Chromosomes & Cancer·S J MurantN J Maitland
Mar 29, 2001·International Journal of Cancer. Journal International Du Cancer·H TakemotoM Monden
May 15, 2002·Genes, Chromosomes & Cancer·Karen M Hajra, Eric R Fearon
Jul 31, 2001·International Journal of Cancer. Journal International Du Cancer·S NakayamaT Matsumura
Dec 28, 2004·Pathology Oncology Research : POR·Dan WuZhenhe Suo
May 6, 2011·Molecules and Cells·Young-Chul ChoiKwanghee Baek
Jul 29, 2008·Japanese Journal of Ophthalmology·Nami NishikioriHiroshi Ohguro
Feb 24, 2012·Investigational New Drugs·Zarina J D'CostaMerilyn H Hibma
May 21, 2011·Molecular Biology Reports·Xinbing SuiXiaotong Hu
May 19, 2005·Cancer Genetics and Cytogenetics·Cathy B WilcoxJulie A DeLoia
May 9, 2002·Mutation Research·Akihiro NakamuraKeiji Mitamura
Jul 24, 1998·Mutation Research·T Sugimura
Mar 24, 2000·Trends in Genetics : TIG·S B Baylin, J G Herman
Feb 18, 1999·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·H ShibanumaH Kato
Aug 8, 1997·Biochimica Et Biophysica Acta·R Mostoslavsky, Y Bergman
Nov 18, 1998·Current Opinion in Cell Biology·T D Tlsty
May 20, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S W TsaoY C Wong
Mar 10, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M ChoY Hiasa
Jul 31, 2001·Surgical Oncology·W G Jiang, R E Mansel
Dec 12, 2001·Critical Reviews in Oncology/hematology·T Minamoto, Z Ronai
Feb 14, 2002·Critical Reviews in Oncology/hematology·Malcolm D MasonWen G Jiang
Aug 23, 2002·Seminars in Cancer Biology·Gordon Strathdee
May 18, 1999·Molecular Medicine Today·P Guilford
Mar 10, 2000·Cytokine & Growth Factor Reviews·S J KimY J Bang
Apr 18, 2000·Mutation Research·T Sugimura, T Ushijima

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.